Suggestions for improving the design of clinical trials in multiple sclerosis—results of a systematic analysis of completed phase III trials

This manuscript reviews the primary and secondary endpoints of pivotal phase III trials with immunomodulatory drugs in multiple sclerosis (MS). Considering the limitations of previous trial designs, we propose new standards for the planning of clinical trials, taking into account latest insights int...

Descripción completa

Detalles Bibliográficos
Autores principales: Gehr, Sinje, Kaiser, Thomas, Kreutz, Reinhold, Ludwig, Wolf-Dieter, Paul, Friedemann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883016/
https://www.ncbi.nlm.nih.gov/pubmed/31832116
http://dx.doi.org/10.1007/s13167-019-00192-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883016/
https://www.ncbi.nlm.nih.gov/pubmed/31832116
http://dx.doi.org/10.1007/s13167-019-00192-z

Ejemplares similares